Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now?

Overview of attention for article published in Neuromuscular Disorders, April 2005

Altmetric Badge

Mentioned by

patent: 52 patents

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 52 patents that reference this research output.

Antisense molecules and methods for treating pathologies

Grant US-12709749-B2

United States of America

Exon skipping compositions for treating muscular dystrophy

Grant US-11932851-B2

United States of America

Antisense molecules and methods for treating pathologies

Grant US-11447776-B2

United States of America

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Grant US-RE48960-E1

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 48 additional patents.